Riskpilot← Back to searchSign inGet full accessAbioche AB
ABActiveOrg 5593309197Gävlegatan 26Research and experimental development on natural sciences and engineering · NACE 7210Est. 20210 employees
Revenue 2024
SEK -1
-100% vs 2023
EBITDA margin
4024600.0%
-107% vs 2023
Equity ratio
99.2%
Financial strength
Net profit 2024
SEK -44K
-110% vs 2023
| Revenue | SEK -1 | -100% |
| EBITDA | SEK -40K | -107% |
| Net profit | SEK -44K | -110% |
| Total assets | SEK 501K | -39% |
| Equity | SEK 497K | -8% |
| Employees | 0 | — |
Legal name
Abioche AB
Org number
5593309197
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18 augusti 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom bioteknisk forskning och utveckling, läkemedelsutveckling, förvaltning av fast och lös egendom samt därmed förenlig verksamhet. Bolaget ska bedriva hälso- och sjukvård samt utföra medicinska konsulttjänster i Sverige och utomlands samt därmed förenlig verksamhet. Bolaget ska bedriva handel och förvaltning av värdepapper, äga noterade och onoterade instrument samt därmed förenlig verksamhet.
Address
Gävlegatan 26
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 600 | 600 | −0 |
| Staff expenses | −0 | −0 | −0 |
| EBITDA | 580 | 557 | −40 |
| Depreciation & amort. | — | — | — |
| EBIT | 580 | 557 | −40 |
| Net financials | −0 | 4 | −3 |
| Profit before tax | 580 | 561 | −44 |
| Tax | −120 | −116 | — |
| Net profit | 461 | 445 | −44 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 603 | 819 | 501 |
| Equity | 486 | 541 | 497 |
| Long-term debt | — | — | — |
| Short-term debt | 118 | 278 | 4 |
| Total debt | 118 | 278 | 4 |
EBITDA margin
-4024600.0%
This company
15.8%
Market median
-25472252% vs market
20222024
Equity ratio
99.2%
This company
38.2%
Market median
+160% vs market
20222024
Return on equity
-8.8%
This company
18.4%
Market median
-148% vs market
20222024
Net profit margin
-4373500.0%
This company
8.1%
Market median
-53993927% vs market
20222024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20222024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (5) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Abioche AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Felicia Jasmine Fransson | Deputy Board Member | 0 companies |
| Robin Gustav Oskar Fröbom | Board of Directors | 0 companies |
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Sophia Linnea Margareta Lemoine | Deputy Board Member | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Petra Maria Nilsson Andersson | Deputy Board Member | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |